Literature DB >> 18361103

Severe immediate type hypersensitivity reactions in 105 German adults: when to diagnose anaphylaxis.

R Treudler1, Y Kozovska, J C Simon.   

Abstract

BACKGROUND: There are no epidemiological data available on anaphylaxis in German adults and so far there has been no consensus on when to diagnose anaphylaxis, mainly due to a lack of generally accepted diagnostic criteria. Recently, an international expert group addressed this issue by suggesting new diagnostic criteria for anaphylaxis. We addressed the usefulness of the suggested diagnostic criteria in German adults and attempted to identify putative trigger factors.
METHODS: Medical records were reviewed for patients seen in 2006 who had suffered any reaction that led to the suspicion of anaphylaxis. Clinical reaction patterns, eliciting factors, serum tryptase concentrations, and the applicability of diagnostic criteria for anaphylaxis were evaluated.
RESULTS: One hundred five patients (78 women and 27 men, aged 18-77 years) were included in the study. The eliciting factors were as follows: drugs (46%), hymenoptera stings (33%), food (11%), physical factors (4%), or unknown (7%). Ninety-five patients (91%) fulfilled criteria for anaphylaxis currently employed in Germany; 58 (58%) of those patients had grade 2-4 reactions. In contrast, only 53 (51%)-and only 19/48 (40%) of those who reacted to drugs-fulfilled the newly proposed criteria. Recurrent anaphylactic episodes were found in 15% of the patients and elevated serum tryptase was observed in 6%.
CONCLUSION: The main eliciting factors for anaphylaxis were hymenoptera stings, drugs, and food. The application of the newly proposed diagnostic criteria did not identify as many patients with severe immediate-type reactions as the graded score currently employed for diagnosis of anaphylaxis in Germany. Further efforts are needed to extend and standardize diagnostic criteria for anaphylaxis.

Entities:  

Mesh:

Year:  2008        PMID: 18361103

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  6 in total

1.  Anaphylaxis in a New York City pediatric emergency department: triggers, treatments, and outcomes.

Authors:  Faith Huang; Kanwaljit Chawla; Kirsi M Järvinen; Anna Nowak-Węgrzyn
Journal:  J Allergy Clin Immunol       Date:  2011-10-22       Impact factor: 10.793

Review 2.  [Adverse drug reactions in elderly people : First data from the Leipzig Research Center for Civilization Diseases (LIFE)].

Authors:  R Treudler; F Walther; P Ahnert; J-C Simon
Journal:  Hautarzt       Date:  2017-01       Impact factor: 0.751

3.  Hypersensitivity to chemotherapeutics: a cross sectional study with 35 desensitisations.

Authors:  Ozlem Goksel; Tuncay Goksel; Gursel Cok; Haydar Karakus; Feza Bacakoglu; Erdem Goker; Ruchan Uslu; Munevver Erdinc
Journal:  Int J Clin Oncol       Date:  2014-07-25       Impact factor: 3.402

4.  Prostaglandin D2 metabolites as a biomarker of in vivo mast cell activation in systemic mastocytosis and rheumatoid arthritis.

Authors:  Catherine Cho; Anna Nguyen; Katherine J Bryant; Sean G O'Neill; H Patrick McNeil
Journal:  Immun Inflamm Dis       Date:  2015-11-25

5.  Prevalence of anaphylaxis and prescription rates of epinephrine auto-injectors in urban and rural areas of Korea.

Authors:  Hyunseok Cho; Jae-Woo Kwon
Journal:  Korean J Intern Med       Date:  2018-10-26       Impact factor: 2.884

6.  Common causes of emergency department visits for anaphylaxis in Korean community hospitals: A cross-sectional study.

Authors:  Hyunseok Cho; Dohyun Kim; Youngkwang Choo; Jungseok Park; Jangwon Choi; Dongwhan Jang; Taekwon Kim; Jae Won Jeong; Jae-Woo Kwon
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.